FDA applies four factors to determine whether a compounded drug is essentially a copy of a commercially available product: Same active ingredient semaglutide or tirzepatide Same route of administration subcutaneous injection Same dosage form injectable solution Same strength matching FDA-approved doses (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg, etc.) If your compounded product meets these four criteria, it is essentially a copy of Ozempic, Wegovy, Mounjaro, or Zepbound and it is illegal to compound, prescribe, or dispense
However, for peptide detection, urine testing has limitations
ISSN 1076-0512
L-Carnitine Nedir
During your visit, youll receive your first injection, take home a three-week supply, and get full training to ensure youre confident and comfortable administering your treatments